Trastuzumab
PrintQuick read
Trastuzumab is not usually recommended in pregnancy. When used in later pregnancy it can reduce the levels of amniotic fluid around your baby.
What is it?
Trastuzumab (Herceptin®, Zercepac®, Herzuma®, Ogivri®, Ontruzant®, Trazimera®) is an antibody therapy used to treat breast and stomach cancers.
Benefits
What are the benefits of using trastuzumab in pregnancy?
Trastuzumab can reduce the growth of some types of tumours. Trastuzumab is only used in pregnancy when the benefits to your health outweigh the possible risks to the baby.
Risks
What are the risks of using trastuzumab in pregnancy?
Very few pregnant women taking trastuzumab have been studied. The available information does not link trastuzumab used in early pregnancy to miscarriage or birth defects, but more information is required to confirm these findings.
Trastuzumab used in later pregnancy can reduce the amount of fluid around your unborn baby. This can cause problems with your baby’s lungs and kidneys. It also increases the chance of preterm birth, which can also cause complications for your baby.
Alternatives
Are there any alternatives to using trastuzumab in pregnancy?
Possibly. Switching to a different drug or having a break from treatment may be an option for some women. However, if trastuzumab was working for you before pregnancy and there is a high chance of relapse without trastuzumab, it may be advisable for you to continue taking it.
If you accidentally conceive while taking trastuzumab, please arrange to see your doctor or specialist as soon as possible to make sure that trastuzumab is still the best treatment and the dose is correct.
No treatment
What if I prefer not to take trastuzumab during pregnancy?
If you are advised to continue trastuzumab in pregnancy, this is because you could become seriously unwell without it.
A doctor will only prescribe medicines when necessary and will be happy to talk through any concerns.
Will I or my baby need extra monitoring?
As part of routine antenatal care in the UK, all women are offered a very detailed scan at around 20 weeks of pregnancy to check the baby’s development. No further scans to check for birth defects will be required after use of trastuzumab in early pregnancy. However, trastuzumab in later pregnancy can affect the amniotic fluid level, and so additional monitoring of fluid levels and your baby’s wellbeing will be recommended if you are using trastuzumab after the first trimester.
Are there any risks to my baby if the father has used trastuzumab?
There is currently no evidence that trastuzumab used by the father can harm the baby through effects on the sperm.
Who can I talk to if I have questions?
If you have any questions regarding the information in this leaflet, please discuss them with your health care provider. They can access more detailed medical and scientific information from www.uktis.org.